We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01387841
Recruitment Status : Completed
First Posted : July 6, 2011
Last Update Posted : July 24, 2013
Information provided by (Responsible Party):

Study Description
Brief Summary:
  • This randomized controlled three arm study compares the effects of a yoga intervention with jacobsons progressive muscle relaxation training and only standard of care in chemotherapy naive cancer patients.
  • This study will also assess the neurophysiological correlates of nausea and vomiting and assess if effects of intervention on nausea and vomiting outcomes are mediated by changes in gastric motility (electrogastrogram) or stress arousal (cardiac autonomic function and sympathetic skin response) or self reported anxiety.

Condition or disease Intervention/treatment Phase
Breast Cancer Malignant Female Reproductive System Neoplasm Lymphomas Chemotherapy-induced Nausea and Vomiting Behavioral: yoga Behavioral: Jacobsons PMRT group Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Comparison of Yoga Versus Relaxation on Chemotherapy Induced Nausea and Vomiting (CINV) Outcomes Following Chemotherapy
Study Start Date : May 2010
Primary Completion Date : December 2012
Study Completion Date : January 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Yoga group
Yoga intervention with standard antiemetic care
Behavioral: yoga
Postures,relaxation techniques
Active Comparator: PMRT/Jacobsons Relaxation training
25 minutes of progressive muscle relaxation training will be given to this group with standard antiemetic care
Behavioral: Jacobsons PMRT group
jacobsons Progressive muscle relaxation training involving 16 muscle groups
Other Name: PMRT
No Intervention: Standard antiemetic care
Standard antiemetic care only

Outcome Measures

Primary Outcome Measures :
  1. Effect of yoga on chemotherapy induced nausea and vomiting [ Time Frame: 4 months (prior to every cycle of chemotherapy,for 4 cycles) ]
    This study is to evaluate the effects of yoga intervention vs. Jacobsons progressive muscle relaxation vs. standard of care only on chemotherapy induced nausea and emesis (CINV) outcomes

Secondary Outcome Measures :
  1. Quality of life after chemotherapy [ Time Frame: 4 months ]
    Here we evaluate the effects of yoga intervention on secondary outcomes such as quality of life and anxiety states

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients with gynecologic malignancies (breast, ovary) and Lymphomas.
  • Age between 30-70 years.
  • Chemotherapy naïve.
  • High school education.

Exclusion Criteria:

  • Those with brain metastases
  • Concurring medical condition likely to influence survival
  • Uncontrolled diabetes and hypertension
  • GI metastases, peritoneal fluid, uraemia
  • Neurological disorders such as Parkinson's disease, myotonic dystrophy etc.
  • GI obstruction and past H/o abdominal surgeries.
  • Cognitive impairments.
  • Regular participation in a behavioral intervention/yoga in the last six months
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01387841

Health Care Global
Bangalore, Karnataka, India, 560027
Sponsors and Collaborators
Bharath Charitable Cancer Hospital and Institute
Bangalore Institute of Oncology
Principal Investigator: RAGHAVENDRA RAO, PHD HCG
More Information

Responsible Party: Dr Raghavendra Rao M, Senior Scientist and Head CAM pROGRAM, Bharath Charitable Cancer Hospital and Institute
ClinicalTrials.gov Identifier: NCT01387841     History of Changes
Other Study ID Numbers: Y010810
First Posted: July 6, 2011    Key Record Dates
Last Update Posted: July 24, 2013
Last Verified: July 2013

Keywords provided by Dr Raghavendra Rao M, Bharath Charitable Cancer Hospital and Institute:

Additional relevant MeSH terms:
Genital Neoplasms, Female
Signs and Symptoms, Digestive
Signs and Symptoms
Urogenital Neoplasms
Neoplasms by Site
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents